Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes - Wikidata - wikimedia - TriplyDB

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes

http://www.wikidata.org/entity/Q24651802

about

miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia Genetic and epigenetic alterations in pancreatic carcinogenesis miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma MicroRNA mir-16 is anti-proliferative in enterocytes and exhibits diurnal rhythmicity in intestinal crypts The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs MicroRNAs: control and loss of control in human physiology and disease MicroRNAs in mouse models of lymphoid malignancies MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis miRNAs in human cancer Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors MicroRNAs in immune regulation--opportunities for cancer immunotherapy A coding-independent function of gene and pseudogene mRNAs regulates tumour biology Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression miRiad roles for the miR-17-92 cluster in development and disease Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis Inositol phosphatase SHIP1 is a primary target of miR-155 Tumorigenicity of the miR-17-92 cluster distilled Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas miR-19 is a key oncogenic component of mir-17-92 microRNAs and the immune response Resolution of Inflammation: What Controls Its Onset?Clinical significance of microRNAs in chronic and acute human leukemia Interplay Between Metabolism and Oncogenic Process: Role of microRNAs Epigenetics of Peripheral B-Cell Differentiation and the Antibody Response Possible Biomarkers in Blood for Crohn's Disease: Oxidative Stress and MicroRNAs-Current Evidences and Further Aspects to Unravel MicroRNA-155 and Its Role in Malignant Hematopoiesis The functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapy Regulation of Bim in Health and Disease Focus on PTEN Regulation The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis

P2860

Q21091130-91A05C00-31C5-48BA-A5A8-B007FE554D41 Q21195360-4C1E3E97-104D-4CE3-8E7B-FE90A1884FA4 Q21245464-2F4448A2-38E8-4FAB-8AB5-514D57A33153 Q21245471-B300772B-D2EB-4604-BC28-79DEFF8C976F Q24596097-0AA659FF-A123-477F-9020-F12A88015F1D Q24598655-0A48A13F-FBB1-4C82-AB6F-E633E84AC54A Q24606181-99EFEE59-5A4F-4241-9D97-907FA61BB504 Q24610279-C2BF20EC-69CB-4697-ACA5-D1C42F1593D3 Q24617045-60CB363D-629B-4D2C-97EA-6E88B69CBAF3 Q24618086-78BDF437-FE77-42F7-9AF8-EF3858D4AD00 Q24618771-B21ADCB6-33E3-48FE-9B17-A489874DFD27 Q24618980-5E59DD64-52D4-4FEE-B69A-D46704B1C1E2 Q24620604-30BCF42E-F1E9-42F1-B247-7FC93D83ED9A Q24624389-72F9AFCF-4B34-4E15-A903-1937663DE459 Q24624863-4BF5D4B1-FF11-42E7-B5CB-1E63D0556B28 Q24628889-A0E73CBA-8933-4753-9C8A-D275D102D275 Q24629589-DB2E9912-362A-44E3-AE13-139557FCE14F Q24629817-DD14DBAA-7DF6-4C0E-BE01-1FD7A8942B86 Q24631617-C574E450-0936-4FA9-B098-20D18E046744 Q24632651-AEB55506-CCDC-44E9-BA9A-A54A68059401 Q24641913-BFBCD0C8-6204-4944-8B61-CDBD11733DD7 Q24643470-FC74942A-2601-49BD-9811-4A4C5FDC2044 Q24646970-10AD5DA6-8BEC-4255-8FAB-E99583B9E95E Q24648286-D5B024DA-7DE0-4988-9F3C-7DBB12F7E00B Q24648984-ECB227F0-5735-4046-B50B-38E8F63D9230 Q24650776-469EC1E2-371E-46EA-8B02-C5E759019228 Q24652219-1DE29268-5013-4B68-8527-3E1E1A475295 Q24652326-B95D6857-B154-4A78-B8C3-808F40F2C77B Q24655922-C59E55F9-E1D3-403D-9FA9-7ECAA9FEDCE5 Q26747410-C7423913-4A22-4CF9-80F8-FF77AE8BD4B3 Q26749533-7A461300-F8B9-4857-87F8-7EC92D6936D8 Q26770381-AC28EADF-CC24-4C77-A8B7-327EADC6D66A Q26772330-3C3632F6-F376-4BA4-848B-F61CD0AE2E5A Q26773008-0F2569E9-B53D-4477-8851-DBD8C1F10F53 Q26777530-6506471A-CD39-4943-90CA-E998D80F6408 Q26778301-37AFB3C2-2475-49D1-9E97-6270DE8ABFCC Q26781203-9F8544C4-9063-442E-B177-2680BD6756FD Q26797287-FB9A5767-5F8E-4614-8C5D-63CE8AF71CB3 Q26797469-59B5D950-085A-4DFF-A8D7-96DFBE102AA7 Q26800055-24E0C91E-57BB-4A14-B941-A7C90E5E4BBB

P2860

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes

http://www.wikidata.org/entity/Q24651802

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Lymphoproliferative disease an ...... 7-92 expression in lymphocytes

@ast

Lymphoproliferative disease an ...... 7-92 expression in lymphocytes

@en

Lymphoproliferative disease an ...... 7-92 expression in lymphocytes

@nl

type

label

Lymphoproliferative disease an ...... 7-92 expression in lymphocytes

@ast

Lymphoproliferative disease an ...... 7-92 expression in lymphocytes

@en

Lymphoproliferative disease an ...... 7-92 expression in lymphocytes

@nl

prefLabel

Lymphoproliferative disease an ...... 7-92 expression in lymphocytes

@ast

Lymphoproliferative disease an ...... 7-92 expression in lymphocytes

@en

Lymphoproliferative disease an ...... 7-92 expression in lymphocytes

@nl

P1433

Q24651802-BF0DB64F-BE8F-4C0C-8120-1DE9495642CC

P1476

Q24651802-35974ADB-49A0-4C6D-9B54-BF63F5FBA6DE

P2093

Q24651802-049E4380-C363-4F9D-8A5A-545300CDEDE2

Q24651802-98A677AA-D553-42F5-B676-DBC03A2D3616

Q24651802-9BFE84EE-F150-4D4D-97C3-D816A9095493

Q24651802-A20839EF-1866-47AA-A214-AFE4E86B4CFE

Q24651802-A3C60268-393B-4D19-A6DB-7CDA29AA6E16

Q24651802-C5F26095-C9B5-4E6B-9B43-1DF38D5C4629

Q24651802-C608BFBB-865A-4436-BBD5-CF868E1BD6A7

P2860

Q24651802-119F8294-475A-4031-B104-5C9BECC33D04

Q24651802-17F3AB85-F52C-478B-AF5B-2F4CBBC54DFD

Q24651802-1EE76B45-05FC-40F2-B7C3-EA247DBEB617

Q24651802-1F6BEFF1-B6B6-4CD9-B8A7-0865D1F4054E

Q24651802-27A80D7E-CAC2-4230-BDC7-EB3DA56A2A0C

Q24651802-27C0E533-1C4B-4E58-AD7B-C5B08AB555ED

Q24651802-288AA359-684D-4A7C-8459-F0703813135E

Q24651802-2FAAA892-1688-41B5-A0E9-36BE5AD3EC38

Q24651802-32782C0E-1BDE-445D-A8E9-1AB70098D552

Q24651802-3A05426B-5455-433D-BF40-A980F4761792

P2888

Q24651802-D498C677-2AFB-4267-88B1-1C777545A35A

P304

Q24651802-5CE12C12-3051-42D3-B030-422ED2CE9FF1

P31

Q24651802-5F74FE51-1ECF-4981-AC94-6A2A1238345C

P3181

Q24651802-F991937C-33F5-4727-8FBE-9D63B974314A

P356

Q24651802-9C8B4AFA-A614-464F-8B08-4A7B986B0016

P407

Q24651802-E1AD7721-40C5-4723-A18A-B3100D51A5C4

P433

Q24651802-264973A4-B9EF-4282-B35B-8487D817AB14

P478

Q24651802-3B1EC25E-1EA8-4B6F-8797-21D342BE6B76

P50

Q24651802-382B6409-711F-468A-8846-A1C29E28F361

Q24651802-75384E56-FDA5-4766-B367-6E4DE7B11AF7

P577

Q24651802-4B2D0B2B-2799-492C-9F10-2E204064EDF5

P5875

Q24651802-C19E77C9-F43D-48BE-A505-946F7E77DE15

P6179

Q24651802-391E1F1E-EAA8-4D4C-B45B-FD47FCECFE5A

P698

Q24651802-283DCC08-72E2-451F-9EC4-D206E596F72F

P921

Q24651802-B5256207-8053-489A-8961-C5F3314F1432

P932

Q24651802-91080843-0041-4413-8773-827D4F4B674D

P3181

P356

P1433

Nature Immunology

P1476

Lymphoproliferative disease an ...... 7-92 expression in lymphocytes

@en

P2093

Changchun Xiao

http://www.w3.org/2001/XMLSchema#string

Dinis Pedro Calado

http://www.w3.org/2001/XMLSchema#string

Heide Christine Patterson

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Kutok

http://www.w3.org/2001/XMLSchema#string

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Joel M Henderson

http://www.w3.org/2001/XMLSchema#string

Lakshmi Srinivasan

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

The nuclear RNase III Drosha initiates microRNA processing

RNA-binding protein Dnd1 inhibits microRNA access to target mRNA

Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling

MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias

MicroRNA targeting specificity in mammals: determinants beyond seed pairing

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

Prediction of mammalian microRNA targets

Combinatorial microRNA target predictions

A microRNA polycistron as a potential human oncogene

P2888

P304

405-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1634975

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NI1575

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5525492

http://www.w3.org/2001/XMLSchema#string

P6179

1033214741

http://www.w3.org/2001/XMLSchema#string

P698

18327259

http://www.w3.org/2001/XMLSchema#string

P921

P932

2533767

http://www.w3.org/2001/XMLSchema#string